
Rybelsus (semaglutide) is an oral GLP-1 receptor agonist licensed in the UK for type 2 diabetes management. Whilst tiredness is not listed as a common side effect in the MHRA-approved Summary of Product Characteristics, some patients report feeling fatigued when starting treatment. This article explores whether Rybelsus can make you tired, examines alternative causes of fatigue in diabetes, and provides practical guidance on managing symptoms. Understanding the distinction between medication effects and other contributing factors—such as blood glucose fluctuations, nutritional changes, or concurrent conditions—is essential for optimising your diabetes care and overall wellbeing.
Quick Answer: Tiredness is not listed as a common side effect of Rybelsus in UK regulatory data, though some patients report fatigue during treatment.
Rybelsus (semaglutide) is an oral glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. According to the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), tiredness or fatigue is not listed among the common adverse effects of this medication, though some patients anecdotally report feeling more tired when starting or taking Rybelsus.
The mechanism of action of Rybelsus involves mimicking the incretin hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying. These physiological changes might theoretically influence energy levels indirectly. For instance, slowed gastric emptying may lead to reduced calorie intake, which—particularly during the initial adjustment period—could potentially contribute to sensations of low energy, though this connection is not established as causal.
Clinical trial data from the PIONEER programme, which evaluated oral semaglutide, did not identify fatigue as a frequent adverse reaction. The most commonly reported side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and abdominal discomfort.
It is important to distinguish between potential medication effects and tiredness arising from other factors, such as poorly controlled blood glucose levels (both high and low), dietary changes, or concurrent medical conditions. If you are taking Rybelsus alongside insulin or sulphonylureas, hypoglycaemia (low blood sugar) can cause fatigue and should be ruled out by checking your blood glucose levels. If you experience persistent or worsening tiredness whilst taking Rybelsus, discuss this with your GP or diabetes specialist to explore potential underlying causes and appropriate management strategies.

If you are experiencing tiredness whilst taking Rybelsus, several practical strategies may help to alleviate symptoms and improve your overall sense of wellbeing. These approaches focus on optimising nutrition, hydration, sleep quality, and physical activity—all of which play crucial roles in energy regulation.
Nutritional considerations are particularly important. Because Rybelsus slows gastric emptying and reduces appetite, some patients inadvertently consume fewer calories or miss key nutrients. Ensure you are eating balanced meals that include adequate protein, complex carbohydrates, healthy fats, and a variety of fruits and vegetables. Small, frequent meals may be better tolerated than large portions, especially if you experience nausea or early satiety. Monitoring your carbohydrate intake and spacing meals appropriately can also help maintain stable blood glucose levels, which directly influence energy.
Hydration is another essential factor. Dehydration can exacerbate feelings of fatigue and is particularly relevant if you experience gastrointestinal side effects such as vomiting or diarrhoea. Aim to drink plenty of water throughout the day, and consider oral rehydration solutions if fluid losses are significant. Seek urgent medical care if you are unable to keep fluids down for more than 24 hours or show signs of severe dehydration.
Sleep hygiene should not be overlooked. Establish a regular sleep schedule, create a restful bedroom environment, and limit screen time before bed. Poor-quality sleep can compound feelings of tiredness and make it harder to manage diabetes effectively.
Physical activity, even in modest amounts, can paradoxically improve energy levels. Gentle exercise such as walking, swimming, or yoga may help combat fatigue, improve insulin sensitivity, and enhance mood. Discuss an appropriate exercise plan with your healthcare team, particularly if you have other health conditions or mobility concerns.
If side effects are significantly affecting your intake and energy levels, discuss with your diabetes team whether adjusting your Rybelsus dose titration might be appropriate. During periods of illness, follow 'sick day rules' by increasing glucose monitoring and seeking advice if you cannot maintain hydration or if you develop symptoms suggesting ketone production. If fatigue persists despite these measures, further medical evaluation is warranted.
Mounjaro® is the most innovative GLP-1 medication proven to dramatically curb appetite, hunger, and cravings to help professional men achieve substantial weight loss.
Start Here
Wegovy® is a weekly injectable GLP-1 medication with proven effectiveness in reducing appetite, hunger, and cravings to help busy professionals lose significant weight.
Start HereWhilst mild tiredness during the initial weeks of Rybelsus therapy may resolve as your body adjusts, certain warning signs should prompt you to contact your GP or diabetes care team without delay. Recognising when fatigue may indicate a more serious underlying issue is essential for patient safety.
Seek medical advice promptly if you experience:
Severe or worsening fatigue that interferes with daily activities or does not improve over time
Symptoms of hypoglycaemia (low blood sugar), such as shakiness, sweating, confusion, palpitations, or dizziness—particularly if you are taking Rybelsus alongside insulin or a sulphonylurea. Seek urgent medical attention for severe or recurrent hypoglycaemia
Signs of dehydration, including reduced urine output, dark urine, dry mouth, dizziness on standing, or persistent vomiting and diarrhoea. Seek same-day assessment if severe
Unexplained weight loss beyond what is expected from improved glycaemic control and lifestyle changes
Sudden, severe, persistent abdominal pain (possibly radiating to the back) with or without vomiting, which could indicate pancreatitis—a rare but serious condition requiring immediate medical attention
Mood changes, including low mood, anxiety, or loss of interest in usual activities, which may indicate depression
Your healthcare professional will conduct a thorough assessment, which may include reviewing your current medications, checking blood glucose patterns, measuring thyroid function (hypothyroidism is a common cause of fatigue, though not related to Rybelsus), assessing haemoglobin levels to exclude anaemia, and evaluating kidney and liver function. NICE guidance (NG28) on type 2 diabetes management emphasises the importance of individualised care and regular monitoring to optimise treatment outcomes and minimise adverse effects.
If you suspect you are experiencing side effects from Rybelsus, you can report these through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk). Do not stop taking Rybelsus without consulting your doctor, as abrupt discontinuation may lead to worsening glycaemic control.
When evaluating tiredness in patients taking Rybelsus, it is crucial to consider alternative or contributing factors that may be responsible for, or exacerbating, fatigue. A comprehensive approach ensures that underlying conditions are not overlooked and that treatment is appropriately targeted.
Suboptimal glycaemic control is a common cause of fatigue in people with type 2 diabetes. Both hyperglycaemia (high blood sugar) and hypoglycaemia (low blood sugar) can lead to tiredness. Regular self-monitoring of blood glucose, where appropriate, and review of HbA1c levels can help identify patterns. If blood glucose levels remain poorly controlled despite Rybelsus therapy, your diabetes team may need to adjust your treatment regimen.
Anaemia is another important consideration. Iron deficiency anaemia (check ferritin levels), vitamin B12 deficiency (particularly in patients taking metformin long-term), or anaemia of chronic disease can all present with fatigue. A full blood count and relevant vitamin assays can help diagnose these conditions.
Thyroid disorders, particularly hypothyroidism, are more prevalent in people with diabetes and can cause significant tiredness. Thyroid function tests (TSH, free T4) are straightforward investigations that can exclude this diagnosis.
Chronic kidney disease is common in diabetes and can contribute to fatigue. Regular monitoring of kidney function through blood and urine tests is part of standard diabetes care.
Intercurrent infections, even mild ones, can cause persistent tiredness. Clinical assessment and tests such as CRP may be appropriate if infection is suspected.
Sleep disorders, such as obstructive sleep apnoea, are common in individuals with type 2 diabetes, especially those who are overweight. Symptoms include loud snoring, witnessed apnoeas, and excessive daytime sleepiness. If suspected, referral for sleep studies may be appropriate.
Psychological factors, including depression and anxiety, are frequently underdiagnosed in people with chronic conditions. The burden of managing diabetes, alongside medication side effects and lifestyle changes, can impact mental health and contribute to fatigue.
Other medications you are taking may also cause tiredness. Beta-blockers, antihistamines, and certain antidepressants are known culprits. A comprehensive medication review with your GP or pharmacist can identify potential interactions or cumulative sedative effects. Addressing these alternative explanations ensures a holistic approach to managing your symptoms and optimising your overall health.
No, tiredness is not listed as a common side effect in the MHRA-approved product information for Rybelsus. The most frequently reported adverse effects are gastrointestinal symptoms such as nausea, vomiting, and diarrhoea.
Ensure adequate nutrition and hydration, maintain good sleep hygiene, and check your blood glucose levels to rule out hypoglycaemia. If fatigue persists or worsens, contact your GP or diabetes team for assessment of potential underlying causes.
Seek prompt medical attention if you experience severe fatigue interfering with daily activities, symptoms of hypoglycaemia or dehydration, unexplained weight loss, sudden severe abdominal pain, or signs of depression. Do not stop Rybelsus without consulting your doctor.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.